{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T17:49:32Z","timestamp":1759340972883,"version":"3.37.3"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T00:00:00Z","timestamp":1559001600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T00:00:00Z","timestamp":1559001600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1007\/s00213-019-05268-2","type":"journal-article","created":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T23:26:11Z","timestamp":1559085971000},"page":"3147-3158","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Sigma-1 receptor ligand PD144418 and sigma-2 receptor ligand YUN-252 attenuate the stimulant effects of methamphetamine in mice"],"prefix":"10.1007","volume":"236","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9963-2248","authenticated-orcid":false,"given":"Melissa A.","family":"Tapia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John R.","family":"Lever","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan Z.","family":"Lever","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew J.","family":"Will","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric S.","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dennis K.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,5,28]]},"reference":[{"key":"5268_CR1","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/S0028-3908(96)00161-X","volume":"36","author":"HC Akunne","year":"1997","unstructured":"Akunne HC et al (1997) The pharmacology of the novel and selective sigma ligand, PD 144418. Neuropharmacology 36:51\u201362","journal-title":"Neuropharmacology"},{"key":"5268_CR2","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/S0306-4522(00)00014-2","volume":"97","author":"G Alonso","year":"2000","unstructured":"Alonso G, Phan V, Guillemain I, Saunier M, Legrand A, Anoal M, Maurice T (2000) Immunocytochemical localization of the sigma(1) receptor in the adult rat central nervous system. Neuroscience 97:155\u2013170","journal-title":"Neuroscience"},{"key":"5268_CR3","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.bbr.2015.03.065","volume":"287","author":"A Blasio","year":"2015","unstructured":"Blasio A, Valenza M, Iyer MR, Rice KC, Steardo L, Hayashi T, Cottone P, Sabino V (2015) Sigma-1 receptor mediates acquisition of alcohol drinking and seeking behavior in alcohol-preferring rats. Behav Brain Res 287:315\u2013322. \n                    https:\/\/doi.org\/10.1016\/j.bbr.2015.03.065","journal-title":"Behav Brain Res"},{"key":"5268_CR4","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/0361-9230(93)90102-H","volume":"30","author":"DJ Calcagnetti","year":"1993","unstructured":"Calcagnetti DJ, Schechter MD (1993) Extinction of cocaine-induced place approach in rats: a validation of the \"biased\" conditioning procedure. Brain Res Bull 30:695\u2013700","journal-title":"Brain Res Bull"},{"key":"5268_CR5","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/0014-2999(88)90362-7","volume":"154","author":"A Ceci","year":"1988","unstructured":"Ceci A, Smith M, French ED (1988) Activation of the A10 mesolimbic system by the sigma-receptor agonist (+)SKF 10,047 can be blocked by rimcazole, a novel putative antipsychotic. Eur J Pharmacol 154:53\u201357","journal-title":"Eur J Pharmacol"},{"key":"5268_CR6","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/0091-3057(77)90036-3","volume":"6","author":"LL Coughenour","year":"1977","unstructured":"Coughenour LL, McLean JR, Parker RB (1977) A new device for the rapid measurement of impaired motor function in mice. Pharmacol Biochem Behav 6:351\u2013353","journal-title":"Pharmacol Biochem Behav"},{"key":"5268_CR7","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1124\/jpet.301.1.306","volume":"301","author":"AE Derbez","year":"2002","unstructured":"Derbez AE, Mody RM, Werling LL (2002) Sigma(2)-receptor regulation of dopamine transporter via activation of protein kinase C. J Pharmacol Exp Ther 301:306\u2013314","journal-title":"J Pharmacol Exp Ther"},{"key":"5268_CR8","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/S1550-8579(08)80005-8","volume":"5","author":"DE Dluzen","year":"2008","unstructured":"Dluzen DE, Liu B (2008) Gender differences in methamphetamine use and responses: a review. Gend Med 5:24\u201335","journal-title":"Gend Med"},{"key":"5268_CR9","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/978-3-319-50174-1_14","volume":"964","author":"K Fukunaga","year":"2017","unstructured":"Fukunaga K, Moriguchi S (2017) Stimulation of the Sigma-1 receptor and the effects on neurogenesis and depressive behaviors in mice. Adv Exp Med Biol 964:201\u2013211. \n                    https:\/\/doi.org\/10.1007\/978-3-319-50174-1_14","journal-title":"Adv Exp Med Biol"},{"issue":"1","key":"5268_CR10","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.jphs.2014.11.010","volume":"127","author":"Kenji Hashimoto","year":"2015","unstructured":"Hashimoto, K. (2015). Activation of sigma-1 receptor chaperone in the treatment of neuropsychiatric diseases and its clinical implication. Journal of Pharmacological Sciences, 127(1), 6\u20139. \n                    https:\/\/doi.org\/10.1016\/j.jphs.2014.11.010","journal-title":"Journal of Pharmacological Sciences"},{"key":"5268_CR11","doi-asserted-by":"publisher","first-page":"269","DOI":"10.2165\/00023210-200418050-00001","volume":"18","author":"T Hayashi","year":"2004","unstructured":"Hayashi T, Su TP (2004) Sigma-1 receptor ligands: potential in the treatment of neuropsychiatric disorders. CNS Drugs 18:269\u2013284","journal-title":"CNS Drugs"},{"key":"5268_CR12","doi-asserted-by":"publisher","first-page":"267","DOI":"10.2174\/157015905774322516","volume":"3","author":"T Hayashi","year":"2005","unstructured":"Hayashi T, Su T (2005) The sigma receptor: evolution of the concept in neuropsychopharmacology. Curr Neuropharmacol 3:267\u2013280","journal-title":"Curr Neuropharmacol"},{"key":"5268_CR13","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1124\/jpet.109.159244","volume":"332","author":"T Hayashi","year":"2010","unstructured":"Hayashi T, Justinova Z, Hayashi E, Cormaci G, Mori T, Tsai SY, Barnes C, Goldberg SR, Su TP (2010) Regulation of sigma-1 receptors and endoplasmic reticulum chaperones in the brain of methamphetamine self-administering rats. J Pharmacol Exp Ther 332:1054\u20131063. \n                    https:\/\/doi.org\/10.1124\/jpet.109.159244","journal-title":"J Pharmacol Exp Ther"},{"key":"5268_CR14","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.bbr.2016.05.056","volume":"311","author":"LL Ji","year":"2016","unstructured":"Ji LL, Peng JB, Fu CH, Cao D, Li D, Tong L, Wang ZY (2016) Activation of Sigma-1 receptor ameliorates anxiety-like behavior and cognitive impairments in a rat model of post-traumatic stress disorder. Behav Brain Res 311:408\u2013415. \n                    https:\/\/doi.org\/10.1016\/j.bbr.2016.05.056","journal-title":"Behav Brain Res"},{"key":"5268_CR15","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1124\/jpet.116.232728","volume":"358","author":"JL Katz","year":"2016","unstructured":"Katz JL, Hiranita T, Kopajtic TA, Rice KC, Mesangeau C, Narayanan S, Abdelazeem AH, McCurdy CR (2016) Blockade of cocaine or sigma receptor agonist self administration by subtype-selective sigma receptor antagonists. J Pharmacol Exp Ther 358:109\u2013124. \n                    https:\/\/doi.org\/10.1124\/jpet.116.232728","journal-title":"J Pharmacol Exp Ther"},{"key":"5268_CR16","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1208\/s12248-011-9274-9","volume":"13","author":"N Kaushal","year":"2011","unstructured":"Kaushal N, Robson MJ, Vinnakota H, Narayanan S, Avery BA, McCurdy CR, Matsumoto RR (2011) Synthesis and pharmacological evaluation of 6-acetyl-3-(4-(4-(4-fluorophenyl)piperazin-1-yl)butyl)benzo[d]oxazol-2(3H)-one (SN79), a cocaine antagonist, in rodents. AAPS J 13:336\u2013346. \n                    https:\/\/doi.org\/10.1208\/s12248-011-9274-9","journal-title":"AAPS J"},{"key":"5268_CR17","doi-asserted-by":"publisher","first-page":"714","DOI":"10.3389\/fphar.2017.00714","volume":"8","author":"AM Klawonn","year":"2017","unstructured":"Klawonn AM, Nilsson A, R\u00e5dberg CF, Lindstr\u00f6m SH, Ericson M, Granseth B, Engblom D, Fritz M (2017) The Sigma-2 receptor selective agonist Siramesine (Lu 28-179) decreases cocaine-reinforced Pavlovian learning and alters glutamatergic and dopaminergic input to the striatum. Front Pharmacol 8:714. \n                    https:\/\/doi.org\/10.3389\/fphar.2017.00714","journal-title":"Front Pharmacol"},{"key":"5268_CR18","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1124\/jpet.114.216671","volume":"351","author":"JR Lever","year":"2014","unstructured":"Lever JR, Miller DK, Fergason-Cantrell EA, Green CL, Watkinson LD, Carmack TL, Lever SZ (2014) Relationship between cerebral sigma-1 receptor occupancy and attenuation of cocaine's motor stimulatory effects in mice by PD144418. J Pharmacol Exp Ther 351:153\u2013163. \n                    https:\/\/doi.org\/10.1124\/jpet.114.216671","journal-title":"J Pharmacol Exp Ther"},{"key":"5268_CR19","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1007\/s002130050449","volume":"134","author":"Y Li","year":"1997","unstructured":"Li Y, Vartanian AJ, White FJ, Xue CJ, Wolf ME (1997) Effects of the AMPA receptor antagonist NBQX on the development and expression of behavioral sensitization to cocaine and amphetamine. Psychopharmacology 134:266\u2013276","journal-title":"Psychopharmacology"},{"key":"5268_CR20","doi-asserted-by":"publisher","first-page":"59345","DOI":"10.18632\/oncotarget.19581","volume":"8","author":"X Liu","year":"2017","unstructured":"Liu X, Fu Y, Yang H, Mavlyutov T, Li J, McCurdy CR, Guo LW, Pattnaik BR (2017) Potential independent action of sigma receptor ligands through inhibition of the Kv2. 1 channel. Oncotarget 8:59345\u201359358. \n                    https:\/\/doi.org\/10.18632\/oncotarget.19581","journal-title":"Oncotarget"},{"key":"5268_CR21","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.bmcl.2003.09.083","volume":"14","author":"RH Mach","year":"2004","unstructured":"Mach RH, Huang Y, Freeman RA, Wu L, Vangveravong S, Luedtke RR (2004) Conformationally-flexible benzamide analogues as dopamine D3 and sigma 2 receptor ligands. Bioorg Med Chem Lett 14:195\u2013202","journal-title":"Bioorg Med Chem Lett"},{"key":"5268_CR22","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1038\/sj.npp.1301323","volume":"32","author":"R Martin-Fardon","year":"2007","unstructured":"Martin-Fardon R, Maurice T, Aujla H, Bowen WD, Weiss F (2007) Differential effects of sigma1 receptor blockade on self-administration and conditioned reinstatement motivated by cocaine vs natural reward. Neuropsychopharmacology 32:1967\u20131973. \n                    https:\/\/doi.org\/10.1038\/sj.npp.1301323","journal-title":"Neuropsychopharmacology"},{"key":"5268_CR23","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/0014-2999(95)00208-3","volume":"280","author":"RR Matsumoto","year":"1995","unstructured":"Matsumoto RR, Bowen WD, Tom MA, Vo VN, Truong DD, De Costa BR (1995) Characterization of two novel sigma receptor ligands: antidystonic effects in rats suggest sigma receptor antagonism. Eur J Pharmacol 280:301\u2013310","journal-title":"Eur J Pharmacol"},{"key":"5268_CR24","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.pbb.2006.12.011","volume":"86","author":"RR Matsumoto","year":"2007","unstructured":"Matsumoto RR, Pouw B, Mack AL, Daniels A, Coop A (2007) Effects of UMB24 and (+\/\u2212)-SM 21, putative sigma2-preferring antagonists, on behavioral toxic and stimulant effects of cocaine in mice. Pharmacol Biochem Behav 86:86\u201391. \n                    https:\/\/doi.org\/10.1016\/j.pbb.2006.12.011","journal-title":"Pharmacol Biochem Behav"},{"key":"5268_CR25","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.euroneuro.2008.07.006","volume":"18","author":"RR Matsumoto","year":"2008","unstructured":"Matsumoto RR, Shaikh J, Wilson LL, Vedam S, Coop A (2008) Attenuation of methamphetamine-induced effects through the antagonism of sigma (sigma) receptors: evidence from in vivo and in vitro studies. Eur Neuropsychopharmacol 18:871\u2013881. \n                    https:\/\/doi.org\/10.1016\/j.euroneuro.2008.07.006","journal-title":"Eur Neuropsychopharmacol"},{"key":"5268_CR26","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/S0149-7634(02)00017-9","volume":"26","author":"T Maurice","year":"2002","unstructured":"Maurice T, Martin-Fardon R, Romieu P, Matsumoto RR (2002) Sigma(1) (sigma(1)) receptor antagonists represent a new strategy against cocaine addiction and toxicity. Neurosci Biobehav Rev 26:499\u2013527","journal-title":"Neurosci Biobehav Rev"},{"key":"5268_CR27","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/S0091-3057(03)00002-9","volume":"74","author":"T Maurice","year":"2003","unstructured":"Maurice T, Casalino M, Lacroix M, Romieu P (2003) Involvement of the sigma 1 receptor in the motivational effects of ethanol in mice. Pharmacol Biochem Behav 74:869\u2013876","journal-title":"Pharmacol Biochem Behav"},{"key":"5268_CR28","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.neulet.2013.08.051","volume":"554","author":"DK Miller","year":"2013","unstructured":"Miller DK, Oelrichs CE, Sage AS, Sun GY, Simonyi A (2013) Repeated resveratrol treatment attenuates methamphetamine-induced hyperactivity and [3H]dopamine overflow in rodents. Neurosci Lett 554:53\u201358. \n                    https:\/\/doi.org\/10.1016\/j.neulet.2013.08.051","journal-title":"Neurosci Lett"},{"key":"5268_CR29","doi-asserted-by":"publisher","first-page":"18676","DOI":"10.1073\/pnas.1008911107","volume":"107","author":"G Navarro","year":"2010","unstructured":"Navarro G, Moreno E, Aymerich M, Marcellino D, McCormick PJ, Mallol J, Cortes A, Casado V, Canela EI, Ortiz J, Fuxe K, Lluis C, Ferre S, Franco R (2010) Direct involvement of sigma-1 receptors in the dopamine D1 receptor-mediated effects of cocaine. Proc Natl Acad Sci U S A 107:18676\u201318681. \n                    https:\/\/doi.org\/10.1073\/pnas.1008911107","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5268_CR30","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/j.neuropharm.2005.04.016","volume":"49","author":"EC Nguyen","year":"2005","unstructured":"Nguyen EC, McCracken KA, Liu Y, Pouw B, Matsumoto RR (2005) Involvement of sigma (sigma) receptors in the acute actions of methamphetamine: receptor binding and behavioral studies. Neuropharmacology 49:638\u2013645. \n                    https:\/\/doi.org\/10.1016\/j.neuropharm.2005.04.016","journal-title":"Neuropharmacology"},{"key":"5268_CR31","doi-asserted-by":"publisher","first-page":"e89985","DOI":"10.1371\/journal.pone.0089985","volume":"9","author":"L Nguyen","year":"2014","unstructured":"Nguyen L, Robson MJ, Healy JR, Scandinaro AL, Matsumoto RR (2014) Involvement of sigma-1 receptors in the antidepressant-like effects of dextromethorphan. PLoS One 9:e89985. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0089985","journal-title":"PLoS One"},{"key":"5268_CR32","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1016\/j.pnpbp.2011.04.008","volume":"35","author":"K Ohi","year":"2011","unstructured":"Ohi K, Hashimoto R, Yasuda Y, Fukumoto M, Yamamori H, Umeda-Yano S, Kamino K, Ikezawa K, Azechi M, Iwase M, Kazui H, Kasai K, Takeda M (2011) The SIGMAR1 gene is associated with a risk of schizophrenia and activation of the prefrontal cortex. Prog Neuro-Psychopharmacol Biol Psychiatry 35:1309\u20131315. \n                    https:\/\/doi.org\/10.1016\/j.pnpbp.2011.04.008","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"5268_CR33","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/S0165-0173(97)00021-0","volume":"25","author":"RC Pierce","year":"1997","unstructured":"Pierce RC, Kalivas PW (1997) A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants. Brain Res Brain Res Rev 25:192\u2013216","journal-title":"Brain Res Brain Res Rev"},{"key":"5268_CR34","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/0165-0173(93)90013-P","volume":"18","author":"TE Robinson","year":"1993","unstructured":"Robinson TE, Berridge KC (1993) The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res Brain Res Rev 18:247\u2013291","journal-title":"Brain Res Brain Res Rev"},{"key":"5268_CR35","doi-asserted-by":"publisher","first-page":"902","DOI":"10.2174\/138161212799436601","volume":"18","author":"MJ Robson","year":"2012","unstructured":"Robson MJ, Noorbakhsh B, Seminerio MJ, Matsumoto RR (2012) Sigma-1 receptors: potential targets for the treatment of substance abuse. Curr Pharm Des 18:902\u2013919","journal-title":"Curr Pharm Des"},{"key":"5268_CR36","doi-asserted-by":"publisher","first-page":"156","DOI":"10.2174\/1874473711003030156","volume":"3","author":"KR Rodvelt","year":"2010","unstructured":"Rodvelt KR, Miller DK (2010) Could sigma receptor ligands be a treatment for methamphetamine addiction? Curr Drug Abuse Rev 3:156\u2013162","journal-title":"Curr Drug Abuse Rev"},{"key":"5268_CR37","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.pbb.2010.11.016","volume":"97","author":"KR Rodvelt","year":"2011","unstructured":"Rodvelt KR, Lever SZ, Lever JR, Blount LR, Fan KH, Miller DK (2011) SA 4503 attenuates cocaine-induced hyperactivity and enhances methamphetamine substitution for a cocaine discriminative stimulus. Pharmacol Biochem Behav 97:676\u2013682. \n                    https:\/\/doi.org\/10.1016\/j.pbb.2010.11.016","journal-title":"Pharmacol Biochem Behav"},{"key":"5268_CR38","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/S0893-133X(01)00391-8","volume":"26","author":"P Romieu","year":"2002","unstructured":"Romieu P, Phan VL, Martin-Fardon R, Maurice T (2002) Involvement of the sigma(1) receptor in cocaine-induced conditioned place preference: possible dependence on dopamine uptake blockade. Neuropsychopharmacology 26:444\u2013455. \n                    https:\/\/doi.org\/10.1016\/S0893-133X(01)00391-8","journal-title":"Neuropsychopharmacology"},{"key":"5268_CR39","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s00213-003-1670-0","volume":"172","author":"ME Roth","year":"2004","unstructured":"Roth ME, Carroll ME (2004) Sex differences in the acquisition of IV methamphetamine self-administration and subsequent maintenance under a progressive ratio schedule in rats. Psychopharmacology 172:443\u2013449. \n                    https:\/\/doi.org\/10.1007\/s00213-003-1670-0","journal-title":"Psychopharmacology"},{"key":"5268_CR40","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3389\/fpsyt.2015.00091","volume":"6","author":"J Ruda-Kucerova","year":"2015","unstructured":"Ruda-Kucerova J, Amchova P, Babinska Z, Dusek L, Micale V, Sulcova A (2015) Sex differences in the reinstatement of methamphetamine seeking after forced abstinence in Sprague-Dawley rats. Front Psychiatry 6:91. \n                    https:\/\/doi.org\/10.3389\/fpsyt.2015.00091","journal-title":"Front Psychiatry"},{"key":"5268_CR41","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.bbr.2008.11.036","volume":"198","author":"V Sabino","year":"2009","unstructured":"Sabino V, Cottone P, Parylak SL, Steardo L, Zorrilla EP (2009a) Sigma-1 receptor knockout mice display a depressive-like phenotype. Behav Brain Res 198:472\u2013476. \n                    https:\/\/doi.org\/10.1016\/j.bbr.2008.11.036","journal-title":"Behav Brain Res"},{"key":"5268_CR42","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1038\/npp.2008.192","volume":"34","author":"V Sabino","year":"2009","unstructured":"Sabino V, Cottone P, Zhao Y, Iyer MR, Steardo L, Steardo L, Rice KC, Conti B, Koob GF, Zorrilla EP (2009b) The sigma-receptor antagonist BD-1063 decreases ethanol intake and reinforcement in animal models of excessive drinking. Neuropsychopharmacology 34:1482\u20131493. \n                    https:\/\/doi.org\/10.1038\/npp.2008.192","journal-title":"Neuropsychopharmacology"},{"key":"5268_CR43","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1038\/npp.2011.5","volume":"36","author":"V Sabino","year":"2011","unstructured":"Sabino V, Cottone P, Blasio A, Iyer MR, Steardo L, Rice KC, Conti B, Koob GF, Zorrilla EP (2011) Activation of sigma-receptors induces binge-like drinking in Sardinian alcohol-preferring rats. Neuropsychopharmacology 36:1207\u20131218. \n                    https:\/\/doi.org\/10.1038\/npp.2011.5","journal-title":"Neuropsychopharmacology"},{"key":"5268_CR44","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.pbb.2013.07.006","volume":"110","author":"AS Sage","year":"2013","unstructured":"Sage AS, Oelrichs CE, Davis DC, Fan KH, Nahas RI, Lever SZ, Lever JR, Miller DK (2013) Effects of N-phenylpropyl-N'-substituted piperazine sigma receptor ligands on cocaine-induced hyperactivity in mice. Pharmacol Biochem Behav 110:201\u2013207. \n                    https:\/\/doi.org\/10.1016\/j.pbb.2013.07.006","journal-title":"Pharmacol Biochem Behav"},{"key":"5268_CR45","doi-asserted-by":"publisher","first-page":"2228","DOI":"10.1038\/s41467-017-02087-x","volume":"8","author":"DO Sambo","year":"2017","unstructured":"Sambo DO, Lin M, Owens A, Lebowitz JJ, Richardson B, Jagnarine DA, Shetty M, Rodriquez M, Alonge T, Ali M, Katz J, Yan L, Febo M, Henry LK, Bruijnzeel AW, Daws L, Khoshbouei H (2017) The sigma-1 receptor modulates methamphetamine dysregulation of dopamine neurotransmission. Nat Commun 8:2228. \n                    https:\/\/doi.org\/10.1038\/s41467-017-02087-x","journal-title":"Nat Commun"},{"key":"5268_CR46","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1097\/00008877-200004000-00003","volume":"11","author":"C Sanchez","year":"2000","unstructured":"Sanchez C, Papp M (2000) The selective sigma2 ligand Lu 28-179 has an antidepressant-like profile in the rat chronic mild stress model of depression. Behav Pharmacol 11:117\u2013124","journal-title":"Behav Pharmacol"},{"key":"5268_CR47","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1038\/s41386-018-0067-z","volume":"43","author":"LL Scott","year":"2018","unstructured":"Scott LL, Sahn JJ, Ferragud A, Yen RC, Satarasinghe PN, Wood MD, Hodges TR, Shi T, Prakash BA, Friese KM, Shen A, Sabino V, Pierce JT, Martin SF (2018) Small molecule modulators of sigma2R\/Tmem97 reduce alcohol withdrawal-induced behaviors. Neuropsychopharmacology 43:1867\u20131875. \n                    https:\/\/doi.org\/10.1038\/s41386-018-0067-z","journal-title":"Neuropsychopharmacology"},{"key":"5268_CR48","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/S0304-3940(97)00768-4","volume":"236","author":"PD Shilling","year":"1997","unstructured":"Shilling PD, Kelsoe JR, Segal DS (1997) Dopamine transporter mRNA is up-regulated in the substantia nigra and the ventral tegmental area of amphetamine-sensitized rats. Neurosci Lett 236:131\u2013134","journal-title":"Neurosci Lett"},{"key":"5268_CR49","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1007\/s00213-004-1779-9","volume":"175","author":"R Stefanski","year":"2004","unstructured":"Stefanski R, Justinova Z, Hayashi T, Takebayashi M, Goldberg SR, Su TP (2004) Sigma1 receptor upregulation after chronic methamphetamine self-administration in rats: a study with yoked controls. Psychopharmacology 175:68\u201375. \n                    https:\/\/doi.org\/10.1007\/s00213-004-1779-9","journal-title":"Psychopharmacology"},{"key":"5268_CR50","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.pneurobio.2005.04.003","volume":"75","author":"D Sulzer","year":"2005","unstructured":"Sulzer D, Sonders MS, Poulsen NW, Galli A (2005) Mechanisms of neurotransmitter release by amphetamines: a review. Prog Neurobiol 75:406\u2013433. \n                    https:\/\/doi.org\/10.1016\/j.pneurobio.2005.04.003","journal-title":"Prog Neurobiol"},{"key":"5268_CR51","first-page":"PL129","volume":"50","author":"H Ujike","year":"1992","unstructured":"Ujike H, Kanzaki A, Okumura K, Akiyama K, Otsuki S (1992) Sigma (sigma) antagonist BMY 14802 prevents methamphetamine-induced sensitization. Life Sci 50:PL129\u2013PL134","journal-title":"Life Sci"},{"key":"5268_CR52","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/0014-2999(95)00693-1","volume":"296","author":"H Ujike","year":"1996","unstructured":"Ujike H, Kuroda S, Otsuki S (1996) Sigma receptor antagonists block the development of sensitization to cocaine. Eur J Pharmacol 296:123\u2013128. \n                    https:\/\/doi.org\/10.1016\/0014-2999(95)00693-1","journal-title":"Eur J Pharmacol"},{"key":"5268_CR53","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s002130000493","volume":"151","author":"LJ Vanderschuren","year":"2000","unstructured":"Vanderschuren LJ, Kalivas PW (2000) Alterations in dopaminergic and glutamatergic transmission in the induction and expression of behavioral sensitization: a critical review of preclinical studies. Psychopharmacology 151:99\u2013120","journal-title":"Psychopharmacology"},{"key":"5268_CR54","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1037\/0033-295X.94.4.469","volume":"94","author":"RA Wise","year":"1987","unstructured":"Wise RA, Bozarth MA (1987) A psychomotor stimulant theory of addiction. Psychol Rev 94:469\u2013492","journal-title":"Psychol Rev"},{"key":"5268_CR55","first-page":"473","volume":"266","author":"JM Witkin","year":"1993","unstructured":"Witkin JM, Terry P, Menkel M, Hickey P, Pontecorvo M, Ferkany J, Katz JL (1993) Effects of the selective sigma receptor ligand, 6-[6-(4-hydroxypiperidinyl)hexyloxy]-3-methylflavone (NPC 16377), on behavioral and toxic effects of cocaine. J Pharmacol Exp Ther 266:473\u2013482","journal-title":"J Pharmacol Exp Ther"},{"key":"5268_CR56","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1124\/jpet.109.161398","volume":"333","author":"YT Xu","year":"2010","unstructured":"Xu YT, Kaushal N, Shaikh J, Wilson LL, Mesangeau C, McCurdy CR, Matsumoto RR (2010) A novel substituted piperazine, CM156, attenuates the stimulant and toxic effects of cocaine in mice. J Pharmacol Exp Ther 333:491\u2013500. \n                    https:\/\/doi.org\/10.1124\/jpet.109.161398","journal-title":"J Pharmacol Exp Ther"},{"key":"5268_CR57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4303\/jdar\/235970","volume":"5","author":"Y Yasui","year":"2016","unstructured":"Yasui Y, Su TP (2016) Potential molecular mechanisms on the role of the Sigma-1 receptor in the action of cocaine and methamphetamine. J Drug Alcohol Res 5:1\u201315. \n                    https:\/\/doi.org\/10.4303\/jdar\/235970","journal-title":"J Drug Alcohol Res"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-019-05268-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00213-019-05268-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-019-05268-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,26]],"date-time":"2020-05-26T23:16:55Z","timestamp":1590535015000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00213-019-05268-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,28]]},"references-count":57,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["5268"],"URL":"https:\/\/doi.org\/10.1007\/s00213-019-05268-2","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"type":"print","value":"0033-3158"},{"type":"electronic","value":"1432-2072"}],"subject":[],"published":{"date-parts":[[2019,5,28]]},"assertion":[{"value":"10 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}